510(k) K910270

PREMIXED DIALYSATE FOR HEMODIAFILTRATION by Baxter Healthcare Corp — Product Code KPO

K910270 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "PREMIXED DIALYSATE FOR HEMODIAFILTRATION". The FDA issued a decision of Substantially Equivalent on Apr 18, 1991. The device falls under product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)), a Class II device regulated under 21 CFR 876.5820. Baxter Healthcare Corp has 507 other 510(k) clearances on record.